Prime Stock Recommendation: An MNC Pharma staple for predictable growth & regular income

With Trump’s talk of tariffs dominating headlines, if you too have joined in the quest for stocks that may offer immunity from this threat then this vaccine-maker is one of our picks – Glaxosmithkline Pharmaceuticals Limited. This MNC pharma player has an enduring suite of brands that have withstood challenges, such as the advent of […]

This article is available for Prime register users only​

To read the full article

Register

Login